JPMorgan Raises Apple Price Target to $315 Ahead of Earnings
JPMorgan lifts Apple price target to $315, citing strong iPhone 17 demand despite higher memory costs, and maintains an Overweight rating.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
JPMorgan lifts Apple price target to $315, citing strong iPhone 17 demand despite higher memory costs, and maintains an Overweight rating.
Needham upgrades AppLovin to Buy, raising its price target to $700 and boosting 2026 e-commerce revenue forecasts due to stronger advertiser growth.
Oppenheimer upgrades Relay Therapeutics to Outperform, citing potential upside from competitor trial risks and upcoming VIKTORIA-1 results.
MannKind (MNKD) receives FDA approval for updated Afrezza dosing recommendations, making it easier for patients to switch from insulin injections to inhaled insulin therapy.
SkyWater Technology stock surges 6% as IonQ announces $35/share acquisition creating first vertically integrated quantum platform company worth $1.8 billion.
Baker Hughes reports 11% profit increase in Q4 2025 as gas technology equipment demand offsets weakness in oilfield services business.